Halozyme Therapeutics OverviewHalozyme Therapeutics Income Tax
Income tax expense trends for HALO.
Quarterly Income Tax
$30.28M
↑ 17.66% YoY
As of Mar 2026
Annual Income Tax (TTM)
$154.53M
↑ 29.24% YoY
Trailing 12 months ending Mar 2026
Average Income Tax (Comparison Companies)
Income Tax History
Income Tax Comparison
Annual Income Tax Growth Rate (%)
Loading...
Annual Income Tax Growth (Absolute)
Loading...